glp 1 drugs generic Health Canada has approved the first version of Novo Nordisk's diabetes drug Ozempic in Canada, with Dr Reddy's Laboratories set to market the copycat treatment. The decision comes as several drugmakers Chart: 1 in 8 Prime Labs Quantity:90 CT (3 Bottles)

glp 1 drugs generic Health Canada has approved the first version of Novo Nordisk's diabetes drug Ozempic in Canada, with Dr Reddy's Laboratories set to market the copycat treatment. The decision comes as several drugmakers Chart: 1 in 8 Prime Labs Quantity:90 CT (3 Bottles)

Chart: 1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss | Statista

Dual GIP/GLP-1 agonists now represent the highest-revenue growth segment in the GLP-1 weight loss drug market at 18.4% CAGR , with tirzepatide generating USD 18.3 billion in 2025 revenue through Zepbound and Mounjaro — surpassing Eli Lilly’s entire insulin franchise within two years of commercial launch

Prime Labs

Quantity:90 CT (3 Bottles)

[DOI] [PubMed] [Google Scholar] 16.Stark JE, Cole JL, Ghazarian RN, Klass MJ